These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8623486)

  • 1. Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506.
    Butt TR; Graumann K; Aziz S
    Transplant Proc; 1996 Apr; 28(2):979-80. PubMed ID: 8623486
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifungal effects of cyclosporine and FK 506 are mediated via immunophilin-dependent calcineurin inhibition.
    Heitman J; Cardenas ME; Breuder T; Hemenway C; Muir RS; Lim E; Goetz L; Zhu D; Lorenz M; Dolinski K
    Transplant Proc; 1994 Oct; 26(5):2833-4. PubMed ID: 7524220
    [No Abstract]   [Full Text] [Related]  

  • 3. Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
    Sigal NH; Dumont FJ; Siekierka JJ; Wiederrecht G; Parent SA; Brizuela L
    Transplant Proc; 1991 Dec; 23(6):2846-9. PubMed ID: 1721295
    [No Abstract]   [Full Text] [Related]  

  • 4. Droplet discovery.
    Sikorski R; Peters R
    Science; 1998 Jan; 279(5349):412-3. PubMed ID: 9454334
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of insulin production by FK 506 is caused at the transcriptional level in pancreatic beta cell when FK BP-12 content is relatively high.
    Tamura K; Fujimura T; Tsutsumi T; Nakamura K; Ogawa T; Atumaru C; Hirano Y; Ohara K; Ohtsuka K; Shimomura K
    Transplant Proc; 1995 Feb; 27(1):357-61. PubMed ID: 7533409
    [No Abstract]   [Full Text] [Related]  

  • 6. FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes.
    Bassing CH; Shou W; Muir S; Heitman J; Matzuk MM; Wang XF
    Cell Growth Differ; 1998 Mar; 9(3):223-8. PubMed ID: 9543388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the mode of action of cyclosporine and FK 506.
    Hutchinson IV; Bagnall W; Bryce P; Pufong B; Geraghty P; Brogan I
    Transplant Proc; 1998 Jun; 30(4):959-60. PubMed ID: 9636388
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene expression of FK 506-binding protein.
    Kar S; Carr B
    Transplant Proc; 1991 Dec; 23(6):2880-2. PubMed ID: 1721303
    [No Abstract]   [Full Text] [Related]  

  • 9. Dimeric ligands define a role for transcriptional activation domains in reinitiation.
    Ho SN; Biggar SR; Spencer DM; Schreiber SL; Crabtree GR
    Nature; 1996 Aug; 382(6594):822-6. PubMed ID: 8752278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regulatory system for use in gene transfer.
    Wang Y; O'Malley BW; Tsai SY; O'Malley BW
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8180-4. PubMed ID: 8058776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a negative regulatory function for steroid receptors.
    McDonnell DP; Vegeto E; O'Malley BW
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10563-7. PubMed ID: 1438251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stress regulatory network for co-ordinated activation of proteasome expression mediated by yeast heat shock transcription factor.
    Hahn JS; Neef DW; Thiele DJ
    Mol Microbiol; 2006 Apr; 60(1):240-51. PubMed ID: 16556235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug target validation and identification of secondary drug target effects using DNA microarrays].
    Owa T
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1808-9. PubMed ID: 18051436
    [No Abstract]   [Full Text] [Related]  

  • 14. TAXI/UAS: A molecular switch to control expression of genes in vivo.
    Delort JP; Capecchi MR
    Hum Gene Ther; 1996 May; 7(7):809-20. PubMed ID: 8860833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel domain of the yeast heat shock factor that regulates its activation function.
    Sakurai H; Fukasawa T
    Biochem Biophys Res Commun; 2001 Jul; 285(3):696-701. PubMed ID: 11453649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cell growth switch.
    Sikorski R; Peters R
    Science; 1997 Jun; 276(5320):1891. PubMed ID: 9206844
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
    Lin VC; Aw SE; Ng EH; Ng EH; Tan MG
    Br J Cancer; 2001 Dec; 85(12):1978-86. PubMed ID: 11747343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomic structure of progesterone complexed with its receptor.
    Williams SP; Sigler PB
    Nature; 1998 May; 393(6683):392-6. PubMed ID: 9620806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
    Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells.
    Sheshgiri R; Rao V; Tumiati LC; Xiao R; Prodger JL; Badiwala M; Librach C; Delgado DH
    Circulation; 2008 Sep; 118(14 Suppl):S58-64. PubMed ID: 18824770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.